ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
68,745.82
0.34%
S&P 500
5,304.72
0.70%
Dow Jones
39,069.59
0.01%
US Dollar vs Yen
156.738
-0.09%
Brent Oil
81.945
-0.04%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NYSE
  6. Allurion Technologies Inc (ALUR)

  7. Allurion Technologies Inc (ALUR) ニュース

ALUR

Allurion Technologies (ALUR)

Allurion Technologies Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NYSE:ALUR
日付受信時刻ニュースソース見出しコード企業名
2024/05/1521 : 00Business WireAllurion Announces Three Scientific Presentations at the European Congress on Obesity, Including Study on Lean Mass Preservation for Sustainable, Healthy Weight LossNYSE:ALURAllurion Technologies Inc
2024/05/1505 : 39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:ALURAllurion Technologies Inc
2024/05/1421 : 05Edgar (US Regulatory)Form 8-K - Current reportNYSE:ALURAllurion Technologies Inc
2024/05/1421 : 00Business WireAllurion Reports First Quarter 2024 Financial Results and Provides Business UpdateNYSE:ALURAllurion Technologies Inc
2024/05/0808 : 12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ALURAllurion Technologies Inc
2024/05/0709 : 22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ALURAllurion Technologies Inc
2024/05/0221 : 00Business WireAllurion Announces Three Scientific Presentations at IFSO-European Chapter 2024, Including First-Ever 3-Year Weight Maintenance SurveyNYSE:ALURAllurion Technologies Inc
2024/04/3021 : 30Business WireAllurion Announces Preliminary First Quarter 2024 ResultsNYSE:ALURAllurion Technologies Inc
2024/04/1721 : 31Business WireAllurion Closes $48 Million Convertible Senior Secured Note Financing with RTW InvestmentsNYSE:ALURAllurion Technologies Inc
2024/04/0421 : 00Business WireAllurion Expands Virtual Care Suite to the United StatesNYSE:ALURAllurion Technologies Inc
2024/03/2121 : 00Business WireAllurion Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 GuidanceNYSE:ALURAllurion Technologies Inc
2024/03/1321 : 30Business WireAllurion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services ConferenceNYSE:ALURAllurion Technologies Inc
2024/03/1221 : 00Business WireMilena Alberti-Perez Joins Allurion Board of Directors as Audit Committee ChairNYSE:ALURAllurion Technologies Inc
2024/03/0422 : 30Business WireAllurion to Report Fourth Quarter 2023 Financial Results on March 21, 2024NYSE:ALURAllurion Technologies Inc
2024/02/2106 : 05Business WireAllurion to Participate in Cowen’s 44th Annual Health Care ConferenceNYSE:ALURAllurion Technologies Inc
2024/02/0822 : 30Business WireAllurion to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceNYSE:ALURAllurion Technologies Inc
2024/01/2922 : 00Business WireBrendan Gibbons Appointed Chief Legal Officer at Allurion TechnologiesNYSE:ALURAllurion Technologies Inc
2024/01/2323 : 04Business WireSomerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight LossNYSE:ALURAllurion Technologies Inc
2024/01/2322 : 15Business WireWorld first : Somerset NHS Foundation Trust Treats First Patients with Allurion Balloon for Pre-Surgical Weight LossNYSE:ALURAllurion Technologies Inc
2024/01/1722 : 00Business WireAllurion's Virtual Care Suite Digital Platform Accelerates Commercial Expansion With New Strategic PartnershipsNYSE:ALURAllurion Technologies Inc
2024/01/1122 : 00Business WireAllurion Announces Publication of Randomized, Double-Blind Study Demonstrating Significant Improvement in Obesity-Related Co-MorbiditiesNYSE:ALURAllurion Technologies Inc
2024/01/0822 : 00Business WireAllurion Announces Preliminary Fourth Quarter and Full Year 2023 Results and Provides 2024 OutlookNYSE:ALURAllurion Technologies Inc
2024/01/0522 : 00Business WireNew research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion ProgramNYSE:ALURAllurion Technologies Inc
2024/01/0222 : 00Business WireAllurion’s Digital Platform Gains Traction with Expanded Strategic PartnershipNYSE:ALURAllurion Technologies Inc
2023/11/1322 : 00Business WireAllurion Reports Third Quarter 2023 Financial Results and Provides Business UpdateNYSE:ALURAllurion Technologies Inc
2023/11/0706 : 05Business WireAllurion to Participate in the Jefferies London Healthcare ConferenceNYSE:ALURAllurion Technologies Inc
2023/11/0622 : 00Business WireAllurion to Report Third Quarter 2023 Financial Results on November 13, 2023NYSE:ALURAllurion Technologies Inc
2023/10/1121 : 00Business WireAllurion Completes Enrollment in Pivotal AUDACITY Trial for the Allurion BalloonNYSE:ALURAllurion Technologies Inc
2023/10/0421 : 00Business WireAllurion Announces Acceptance of Five Abstracts for Presentation at Obesity Week 2023NYSE:ALURAllurion Technologies Inc
2023/09/1821 : 00Business WireAllurion Featured at the 2023 International Bariatric Club Oxford University World CongressNYSE:ALURAllurion Technologies Inc
 Showing the most relevant articles for your search:NYSE:ALUR

最近閲覧した銘柄

USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
RHHBY
Roche (QX)
NASDAQ
GOOGL
Alphabet
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
KO
Coca Cola
NYSE
MRK
Merck
PM
XAUUSD
Gold vs US Dollar
NYSE
NKE
Nike
NYSE
DIS
Walt Disney
NYSE
JPM
JP Morgan Chase
USI
USTECH100
US Tech 100
NYSE
VZ
Verizon Communications
COIN
ETHUSD
Ethereum
NYSE
AXP
American Express
USOTC
BNPQY
BNP Paribas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有